Bicocca Open Archive

Logo unimib boa
PIAZZA, ROCCO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.476
EU - Europa 12.534
AS - Asia 11.516
SA - Sud America 1.789
AF - Africa 216
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 16
Totale 47.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.947
SG - Singapore 4.297
IT - Italia 3.214
CN - Cina 2.844
DE - Germania 2.586
RU - Federazione Russa 1.732
HK - Hong Kong 1.549
BR - Brasile 1.459
VN - Vietnam 1.370
SE - Svezia 1.227
IE - Irlanda 1.193
UA - Ucraina 571
GB - Regno Unito 570
CA - Canada 384
FR - Francia 305
FI - Finlandia 295
IN - India 269
ID - Indonesia 240
KR - Corea 202
TR - Turchia 185
AR - Argentina 145
NL - Olanda 125
PL - Polonia 123
AT - Austria 122
BD - Bangladesh 120
JP - Giappone 112
ZA - Sudafrica 106
DK - Danimarca 104
MX - Messico 88
ES - Italia 79
BE - Belgio 77
IQ - Iraq 60
EC - Ecuador 57
CH - Svizzera 44
LT - Lituania 44
PK - Pakistan 34
CO - Colombia 33
SA - Arabia Saudita 33
BG - Bulgaria 28
MA - Marocco 28
VE - Venezuela 27
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
IR - Iran 25
EU - Europa 22
EG - Egitto 19
PE - Perù 19
CL - Cile 18
KE - Kenya 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 16
IL - Israele 15
JO - Giordania 14
TN - Tunisia 13
DO - Repubblica Dominicana 12
NO - Norvegia 11
NP - Nepal 11
AU - Australia 9
GR - Grecia 9
MY - Malesia 9
RO - Romania 9
AL - Albania 8
BO - Bolivia 8
ET - Etiopia 8
KZ - Kazakistan 8
PH - Filippine 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
JM - Giamaica 7
KG - Kirghizistan 7
CR - Costa Rica 6
HN - Honduras 6
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
UY - Uruguay 5
AM - Armenia 4
DZ - Algeria 4
GT - Guatemala 4
PT - Portogallo 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
BM - Bermuda 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CY - Cipro 3
GE - Georgia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LY - Libia 3
MK - Macedonia 3
MU - Mauritius 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
BB - Barbados 2
BH - Bahrain 2
Totale 47.538
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.898
Singapore 2.667
Ashburn 2.037
Frankfurt am Main 1.582
Hong Kong 1.534
Woodbridge 1.224
Milan 1.190
Dublin 1.162
Chandler 1.067
Fairfield 965
Houston 773
Wilmington 747
Dallas 736
New York 584
Jacksonville 530
Dearborn 507
Beijing 487
Hefei 464
Los Angeles 433
Santa Clara 426
Seattle 417
Ho Chi Minh City 408
Hanoi 322
Cambridge 307
Princeton 302
Shanghai 236
Jakarta 211
Göttingen 205
Seoul 190
Munich 175
Buffalo 173
São Paulo 172
Moscow 168
Nanjing 166
Chicago 150
Altamura 142
The Dalles 123
Lawrence 120
Toronto 111
Boardman 99
Nuremberg 97
Helsinki 92
Guangzhou 91
Tokyo 87
Lachine 85
Kent 83
Rome 83
Warsaw 82
San Diego 81
London 80
Brussels 72
Turku 72
Fürstenwalde 71
Stockholm 65
Monza 64
Romola 63
Vienna 63
Johannesburg 60
Montreal 60
Council Bluffs 59
Denver 58
Fremont 58
Dong Ket 57
Chennai 56
Nanchang 55
Andover 54
Atlanta 54
Ottawa 53
Shenyang 52
Tianjin 52
Brooklyn 49
Lissone 49
Boston 48
Kocaeli 46
Orem 46
Rio de Janeiro 46
Turin 45
Desio 44
Haiphong 42
Da Nang 41
Hebei 41
Poplar 41
Phoenix 40
Changsha 39
Ankara 38
Assago 38
Düsseldorf 35
Mexico City 35
Salt Lake City 35
Jinan 34
Sesto San Giovanni 34
Jiaxing 33
Lappeenranta 33
Carate Brianza 31
Hangzhou 30
Pune 30
San Francisco 30
Como 29
Falls Church 29
Amsterdam 28
Totale 31.408
Salva come PNG Salva come JPEG
Nome #
Longitudinal cancer evolution from single cells 556
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 509
Personalized therapy design for liquid tumors via optimal control theory 508
Characterization of intra-host SARS-CoV-2 variants improves phylogenomic reconstruction and may reveal functionally convergent mutations 501
VERSO: a comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples 452
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 444
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 436
An Optimal Control Framework for the Automated Design of Personalized Cancer Treatments 424
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene 406
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 397
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates 397
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 391
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 380
VERSO: a comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples 378
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years 376
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 371
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 357
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 356
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 355
An Imatinib–non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization 355
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 355
LACE: Inference of cancer evolution models from longitudinal single-cell sequencing data 355
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 352
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 351
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 349
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 347
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 346
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 346
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 344
Variant calling from scRNA-seq data allows the assessment of cellular identity in patient-derived cell lines 340
Imatinib long term effects study: three years of follow-up and assessment 333
Three novel patients derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors 319
Hif1a: A putative modifier of hemochromatosis 319
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 318
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 311
VirMutSig: Discovery and assignment of viral mutational signatures from sequencing data 311
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution 307
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 306
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 305
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib 305
Chronic myeloid leukemia: Second-line drugs of choice 305
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 303
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells 302
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 297
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 297
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 294
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 293
Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data 291
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL) 291
Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by leguay et al 283
Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer 282
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 280
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma 279
A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036 276
A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation 276
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 275
Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling 275
Choosing the right TKI for chronic myeloid leukemia: when the truth lies in "long-term" safety and efficacy 272
Idiopathic erythrocytosis: a germline disease? 271
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 271
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 271
Human chromosome 18 and acrocentrics: A dangerous liaison 271
Whole-Exome Sequencing Data - Identifying Somatic Mutations 270
Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex 268
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants 266
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells 266
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 266
LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution 265
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 265
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 265
Evidence for D276G and L364I Bcr-Abl mutations in Ph plus leukaemic cells obtained from patients resistant to Imatinib 263
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 260
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 259
Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity 259
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 252
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias 251
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 251
Reply to P. Laneuville et al 250
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 248
In Vitro and in Vivo Characterization of Bosutinib as Substrate of the Pglycoprotein Efflux Transporter 248
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 247
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 246
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation 246
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 245
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 236
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 236
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 233
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 232
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 230
Phase ii study with crizotinib in patients with anaplastic lymphoma kinase (alk)-positive lymphoma relapsed/refractory to chemotherapy 229
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses 227
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 227
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 225
Epigenetic Silencing of the Pro-Apoptotic Bim Gene in Glucocorticoid Poor-Responsive Pediatric Acute Lymphoblastic Leukemia, and Its Reversal by Histone Deacetylase Inhibition 225
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 224
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 223
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 219
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution 218
Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data 217
Valproic acid enhances bosutinib cytotoxicity in colon cancer cells 217
Totale 30.497
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.054
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.110 0 0 0 0 0 455 513 448 453 463 342 436
2021/20223.341 313 301 354 244 233 295 225 183 183 227 295 488
2022/20235.119 604 1.360 515 520 400 631 90 242 313 100 183 161
2023/20244.287 162 187 223 260 506 1.076 753 151 308 145 97 419
2024/20259.968 486 867 610 551 843 425 673 370 875 1.608 931 1.729
2025/202612.411 2.912 1.643 1.966 2.898 2.700 292 0 0 0 0 0 0
Totale 48.820